IL-4 in combination with TGF-β favors an alternative pathway of Th1 development independent of IL-12

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4709-4718

  Lingnau, Karen ^a   Hoehn, Petra ^a   Kerdine, Saadia ^a   Koelsch, Stephan ^a   Neudoerfl, Christine ^a   Palm, Norbert ^a   Ruede, Erwin ^a   Schmitt, Edgar ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG SYNERGISM; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED DBA; MICE, TRANSGENIC; OSMOLAR CONCENTRATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032212187     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. + T cells. Annu. Rev. Immunol. 12:635.
2. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
3. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
4. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793.
5. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
6. Schmitt, E., R. Van Brandwijk, H. G. Fischer, and E. Rüde. 1990. Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors. Eur. J. Immunol. 20:1709.
7. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
8. + T-cell subsets in vivo. Immunol. Rev. 123:189.
9. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
10. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379: 343.
11. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
12. Lee, G., L. R. Ellingsworth, S. Gillis, R. Wall, and P. W. Kincade. 1987. [Beta] transforming growth factors are potential regulators of B lymphopoiesis. J. Exp. Med. 166:1290.
13. Keller, J. R., C. Mantel, G. K. Sing, L. R. Ellingsworth, S. K. Ruscetti, and F. W. Ruscetti. 1988. Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 168:737.
14. Siepl, C., S. Bodmer, K. Frei, H. R. MacDonald, R. De Martin, E. Hofer, and A. Fontana. 1988. The glioblastoma-derived T cell suppressor factor/transforming growth factor-β2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor. Eur. J. Immunol. 18:593.
15. Goey, H., J. R. Keller, T. Back, D. L. Longo, F. W. Ruscetti, and R. H. Wiltrout. 1989. Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-β1. J. Immunol. 143:877.
16. Ruegemer, J. J., S. N. Ho, J. A. Augustine, J. W. Schlager, M. P. Bell, D. J. McKean, and R. T. Abraham. 1990. Regulatory effects of transforming growth factor-β on IL-2-and IL-4-dependent T cell-cycle progression. J. Immunol. 144:1767.
17. Cross, D., and J. C. Cambier. 1990. Transforming growth factor β1 has differential effects on B cell proliferation and activation antigen expression. J. Immunol. 144:432.
18. Nagelkerken, L., K. J. Gollob, M. Tielemans, and R. L. Coffman. 1993. Role of transforming growth factor-β in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B. Eur. J. Immunol. 23:2306.
19. Swain, S. L., G. Huston, S. Tonkonogy, and A. Weinberg. 1991. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:2991.
20. Fargeas, C., C. Y. Wu, T. Nakajima, D. Cox, T. Nutman, and G. Delespesse. 1992. Differential effect of transforming growth factor β on the synthesis of Th1-and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 22:2173.
21. Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately, and G. Delespesse. 1993. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J. Immunol. 151:1938.
22. + T cells isolated from different mouse strains. J. Immunol. 155:3788.
23. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stüber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
24. Stüber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of IL-12 secretion. J. Exp. Med. 183:693.
25. Manner, F., J. Magram, J. Ferrante, P. Launois, K. DiPadova, R. Benin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553.
26. lo thymocytes in vivo. Science 250: 1720.
27. Campbell, J. B., T. Grunberger, M. A. Kochman, and S. L. White. 1975. A microplaque reduction assay for human and mouse interferon. Can. J. Microbiol. 21:1247.
28. Spitalny, G. L., and E. A. Havell. 1984. Monoclonal antibody to murine γ interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1560.
29. Prat, M., G. Gribaudo, P. M. Comoglio, G. Cavallo, and S. Landolfo. 1984. Monoclonal antibodies against murine γ interferon. Proc. Natl. Acad. Sci. USA 81:4515.
30. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
31. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
32. Sarmiento, M., D. P. Dialynas, D. W. Laincki, K. A. Wall, M. I. Lorber, M. R. Loken, and F. W. Fitch. 1982. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:135.
33. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
34. Abrams, J. S., M.-G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
35. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30.
36. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:2736.
37. Wenner, C. A., M. L. Güler, S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1996. Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442.
38. + T cells. Eur. J. Immunol. 24:343.
39. Brabletz, T., I. Pfeuffer, E. Schorr, F. Siebelt, T. Wirth, and E. Serfling. 1993. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol. Cell. Biol. 13:1155.
40. Fox, F. E., R. J. Capocasale, H. C. Ford, R. J. Lamb, J. S. Moore, and P. C. Nowell. 1992. Transforming growth factor-β inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res. 11:299.
41. Reinhold, D., U. Bank, F. Buhling, U. Lendeckel, A. J. Ulmer, H. D. Flad, and S. Ansorge. 1994. Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 6:382.
42. Tanaka, T., S. Z. Ben Sasson, and W. E. Paul. 1991. IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli. J. Immunol. 146:3831.
43. + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFN-γ. J. Immunol. 153:3989.
44. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1579.
45. + T cells. J. Exp. Med. 182:1591.
46. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
47. Bost, K. L., S. C. Bieligk, and B. M. Jaffe. 1995. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies: tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response. J. Immunol. 154: 718.
48. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.
49. Barral, A., M. Barral Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90:3442.
50. Barral Netto, M., and A. Barral. 1994. Transforming growth factor-β in tegumentary leishmaniasis. Braz. J. Med. Biol. Res. 27:1.
51. Ramanathan, S., Y. de Kozak, A. Saoudi, O. Goureau, P. H. Van Der Meide, P. Druet, and B. Bellon. 1996. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J. Immunol. 157:2209.
52. Saoudi, A., J. Kuhn, K. Huygen, Y. de Kozak, T. Velu, M. Goldman, P. Druet, and B. Bellon. 1993. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 23:3096.
53. Apte, R. S., and J. Y. Niederkorn. 1996. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 156:2667.
54. Cousins, S. W., M. M. McCabe, D. Danielpour, and J. W. Streilein. 1991. Identification of transforming growth factor-β as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. 32:2201.
55. Jacobs, M. J., A. E. van den Hoek, P. L. van Lent, F. A. van de Loo, L. B. van de Putte, and W. B. van den Berg. 1994. Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 83:390.
56. Müller, K. M., F. Jaunin, I. Masouye, J. H. Saurat, and C. Hauser. 1993. Th2 cells mediate IL-4-dependent local tissue inflammation. J. Immunol. 150:5576.
57. Platzer, C., G. Richter, K. Uberla, W. Muller, H. Blocker, T. Diamantstein, and T. Blankenstein. 1992. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 22:1179.
58. + T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187:307.